Correction to: Autoimmune Cerebellar Ataxia Associated with Anti-Glutamate Receptor δ2 Antibodies: a Rare but Treatable Entity

The Cerebellum https://doi.org/10.1007/s12311-023-01541-5 CORRECTION Correction to: Autoimmune Cerebellar Ataxia Associated with Anti‑Glutamate Receptor δ2 Antibodies: a Rare but Treatable Entity Laura Khatib1 · Le‑Duy Do1,2 · Marie Benaiteau1 · Macarena Villagrán‑García1,2 · Madeleine Scharf3 · Pierre Meyer4,5 · Lydia Abou Haidar4 · Sophie Demeret6 · Jérôme Honnorat1,2 © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023 Correction to: The Cerebellum https://doi.org/10.1007/s12311-023-01523-7 The original version of this article unfortunately contained mistake. One of the author was missed during revision and finalization of the manuscript. The fifth author should be Madeleine Scharf, who is affiliated with the "Institute of Experimental Immunology, affiliated to EURIMMUN Medizinische Labordiagnostika AG, Lübeck". The list of authors must be: Khatib L, Do LD, Benaiteau M, Villagrán-García M, Scharf M, Meyer P, Haidar LA, Demeret S, Honnorat J. The original article has been corrected. Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. The original article can be found online at https://doi.org/10.1007/ s12311-023-01523-7. * Jérôme Honnorat 1 French Reference Center for Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Hôpital Neurologique, 59 Boulevard Pinel, Bron Cedex, 69677 Lyon, France 2 MeLiS—UCBL‑CNRS UMR 5284—INSERM U1314, Université Claude Bernard Lyon 1, Lyon, France 3 Institute of Experimental Immunology, affiliated to EURIMMUN Medizinische Labordiagnostika AG, Lübeck, Germany 4 Pediatric Neurology Department, CHU de Montpellier, Montpellier, France 5 Phymedexp, CNRS, INSERM, Université de Montpellier, Montpellier, France 6 Neurology departement, CHU Pitie Salpetrière, Paris, France 1 Vol.:(0123456789) 3  (...truncated)